ADULT GLIOBLASTOMA
Clinical trials for ADULT GLIOBLASTOMA explained in plain language.
Never miss a new study
Get alerted when new ADULT GLIOBLASTOMA trials appear
Sign up with your email to follow new studies for ADULT GLIOBLASTOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Promising drug combo targets aggressive brain cancers
Disease control OngoingThis early-stage study tested the safety and best dose of a drug called vorinostat when given with the chemotherapy temozolomide for people with malignant gliomas, a type of aggressive brain cancer. The goal was to see if the combination could kill more tumor cells by making them…
Matched conditions: ADULT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 17, 2026 08:18 UTC
-
New drug duo targets Hard-to-Treat brain tumors
Disease control OngoingThis early-phase trial tests a new drug (MLN0128) combined with bevacizumab in people with recurrent glioblastoma (a brain cancer) or other advanced solid tumors that have stopped responding to standard treatments. The main goals are to find the safest dose and understand side ef…
Matched conditions: ADULT GLIOBLASTOMA
Phase: PHASE1 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated May 11, 2026 20:50 UTC